Today's Health News

CDC Signs Off on Moderna, J&J Boosters, Backs Mix ‘n’ Match Shots

Agency plans to release guidance early next week about who might benefit from choosing one booster over another

BNT162b2 Highly Effective Against Delta Variant in Teens

At seven to 21 days after second dose, estimated effectiveness was 90 percent against infection, 93 percent against symptomatic COVID-19

mRNA Vaccine More Effective Booster to ChAdOx1 nCoV-19

Heterologous ChAdOx1 nCoV-19/mRNA prime-boost vaccination more effective than homologous ChAdOx1 nCoV-19/ChAdOx1 nCoV-19

Dysglycemia Risk Up for Women With PCOS, Regardless of BMI

Combined oral contraceptive pill use associated with reduced dysglycemia risk for women with PCOS

Neuroimaging Soon After Trauma May Predict Stress Response

Three clusters replicated in samples with variety of trauma types; clusters showed different patterns of posttrauma symptoms

Geriatrics-Focused Risk Factors ID’d for COVID-19 Death

Indicators other than age alone can be used to determine prognosis in older adults hospitalized with COVID-19

3 Percent of U.S. Cancer Cases Attributable to Physical Inactivity

Population-attributable fraction varied from 3.9 percent for urinary bladder cancer to 16.9 percent for stomach cancer

Proton Pump Inhibitor Use Tied to Less Severe Periodontal Disease

Patients with periodontitis who use proton pump inhibitors have fewer teeth with elevated probing depths for the gap between teeth and gums

Physician’s Briefing Weekly Coronavirus Roundup

Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...

Quitting at Younger Age Cuts Most Smoking-Associated Cancer Mortality Risk

Starting to smoke at any age linked to increased cancer mortality rate ratio, with increased rate ratio for starting at younger age